It has been postulated that a dual inhibitor of ANP (atrial natriuretic peptide) and ACE (angiotensin-converting enzyme) could be a promising drug for hypertension and congestive heart failure. Several peptidomimetic candidates have been reported and are currently being developed. 1, 2) We have also discovered a well-balanced and potent inhibitor, ER-40133 (1), shown in Chart 1. The compound 1 has six chiral centers and a [5.7]-bicyclic ring connected by an amide bond, and thus the development of an industrial scale manufacturing process of 1 represents a significant task.
Synthesis of a New
inseparable by simple crystallization or short-column chromatography to yield the trans isomer (3a). Various attempts were thus made to selectively reduce the trans isomer 3a in the mixture of 3a/3b to give the aminal 4a. Diastereomer specific reduction was investigated using several metal hydride reductants. First, diisobutylaluminium hydride (DIBAL-H) was examined as it has been reported to be a good reductant for N-protected pyroglutamic acid derivatives to give the corresponding aminals. [4] [5] [6] However, reaction with DIBAL-H at Ϫ78°C converted both isomers 3a and 3b to the corresponding aminals (4a, 4b), indicating that it was not a selective reductant. Super hydride LiB(C 2 H 5 ) 3 H has also been reported to be an effective reductant for N-protected 6-oxopipecolic acid derivatives, 7, 8) however, it provided decomposed multi-component mixtures. On the hand, LiAlH(tert-BuO) 3 was found to reduce the trans isomer 3a, but not the cis isomer 3b, which indicated that it is a highly selective reagent. Other reagents like LiBH 4 and NaBH 4 gave complicated mixtures or the corresponding alcohols, respectively.
To confirm the selectivity of the reagent, each isomer (3a, 3b) was separated through preparative HPLC, purified and subjected to LiAlH(tert-BuO) 3 reducing conditions. As expected, the trans isomer 3a was completely converted to the aminal 4a, but the cis isomer 3b remained intact; in contrast to the reaction with DIBAL-H in which 3b was readily con-verted to the aminal 4b (Chart 3). HPLC analysis was carried out to confirm the selectivity in more detail. Since the aminal 4a has a chiral hydroxyl group, the two isomers of 4a were observed independently at retention times of 23 and 27 min. On the other hand, although the aminal 4b has a chiral hydroxyl group, both isomers were observed together at a retention time of 39 min. This 39 min peak was not detected in the reaction mixture of 3a/3b with LiAlH(tert-BuO) 3 , which confirms that the reduction proceeds chemoselectively. Thus, we established a method to obtain the aminal intermediate 4a with the desired configuration. However, there remains the problem of eliminating the unreacted cis isomer 3b from the reaction mixture.
The thiazolidine ring formation step was carried out in accordance with a known method. 9, 10) The mixture of aminal 4a and unreacted cis methyl 3b was treated with L-cysteine methyl ester (Cys-Me · HCl) in the presence of acetic acid and sodium acetate in EtOH overnight to provide the desired thiazolidine derivatives 5a, while the unreacted 3b remained in the reaction mixture. However, the thiazolidine derivative 5a was found to include 1% of isomer 5b. In order to investigate the origin of contamination by the isomer, 5b was prepared through DIBAL-H reduction of 3b and thiazolidination of 4b as shown in Chart 3. Thiazolidination of 4b was found to be slower reaction than that of 4a and gave a 5 : 1 mixture of 5b/5a, indicating that isomerization occurred during the reaction. Detailed investigation of the reaction conditions led to the discovery that acids such as acetic acid or hydrogen chloride promote this isomerization. We concluded that the isomerization is inevitable as long as acids are necessary to catalyze the reaction. From a practical viewpoint, this isomerization was not a serious problem, because if the reaction is stopped within one day, the content of 5b in the product can be controlled to be less than 1%.
In the early stage of synthesis, the mixture of 5a/3b was chromatographed to prepare pure 5a, followed by deprotection of the benzhydryl group with trifluoroacetic acid (TFA) and anisole and subsequent cyclization with 1-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) in the presence of N-methylmorpholine (NMM) in a manner described in a patent 11) (Chart 4). The ring closure took place very smoothly but yielded a 4 : 1 diastereomeric mixture of favorably cyclized (7a) and unfavorably cyclized compounds (7c). The compound cited in the patent was reported to isomerize with toluenesulfonic acid to a more thermodynamically stable compound, which had a similar configuration to 7a. However, compounds 7a/7c were not stable under acidic conditions and were slightly isomerized. Even though each isomer could be separated through silica gel chromatography, a more practical and elegant solution was needed.
The method in Chart 4 is essentially a one-pot synthesis, and consists of three types of reactions: deprotection of the benzhydryl group using more than 10 eq of TFA and anisole, neutralization with NMM, and ring cyclization with EEDQ. As major changes in these reaction conditions were not deemed possible, we reasoned that it was necessary to divide the reactions into independent reactions to investigate the [5.7] -bicylic ring closure reaction in detail. The objective was to obtain 6a as a solid form, and was realized in the following manner. After TFA cleavage treatment of 5a, the crude mixture was added into aqueous HCl solution. The aqueous phase containing the hydrochloride salt of 6a was washed with a mixture of tert-butyl methyl ether (TBME)-nhexane to remove anisole, benzhydrol as well as unreacted 3b. The separated aqueous layer was neutralized with aqueous NaOH solution to pH 3.8, and the free form of 6a was extracted with AcOEt, followed by evaporation and crystallization from a mixture of AcOEt and TBME to give crystalline 6a in about 30% yield based on 2. Thus, we eventually succeeded in isolating 6a as a solid as well as eliminating 3b. However, HPLC analysis using a 1 : 5 mixture of 6a/6b prepared in Chart 3 revealed that 6a isomerized to 6b in the AcOEt extract. As shown in Table 1 , the percentage of 6b in the extract increased from 1% to 12% at 60°C in 5 h. The mechanism of this isomerization was speculated to be intramolecular participation by the carboxylic acid in the thiazolidine ring isomerization. Several attempts were made to precipitate 6a directly from the organic solvent extract. Among several water immisible organic solvents, AcOiso-Bu a) Optical purity was determined by HPLC under the conditions described in the experimental section. b) Chemical purity was determined by HPLC under the conditions described in the experimental section.
was the optimal solvent in terms of extraction efficiency and availability. The AcOiso-Bu extract was directly diluted with 1 vol of hexane or heptane and stirred overnight to afford 6a in similar yield (29%) and purity (97%) to the results obtained with the AcOEt extraction-TBME crystallization method. Thus, we achieved a practical isolation procedure for this key compound 6a.
Next, using the crystalline 6a, [5.7] -bicyclic ring closure was investigated and the results are summarized in Table 2 . First, 6a was treated with EEDQ in AcOEt to give a 7.5 : 1 mixture of 7a/7c ( Table 2 , entry 1). Then, NMM was used as a base to increase the isomer ratio to 21 : 1 ( Table 2 , entry 2). The reaction in THF showed a further improved isomer ratio of 27 : 1, although 20% of 6a remained (Table 2, entry 3). Next, various condensation reagents were examined. Activation of the carboxylic acid with diethyl chlorophosphite gave a good result in terms of the isomer ratio (30 : 1), however showed poor conversion ( Table 2 , entry 4). Oxalyl chloride resulted in poor conversion to give a complicated mixture ( Table 2 , entry 5). In contrast, ethyl chloroformate drastically improved reaction conversion and isomer ratio. When the reaction was carried out with 1.2 eq of ClCOOEt and 1.5 eq of triethylamine at 0°C in tetrahydrofuran (THF), 6a was consumed almost completely within 1 h and the isomer ratio was surprisingly excellent (237 : 1) (Table 2, entry 6). As this cyclization reaction is a "conformational stereoselective reaction", reaction temperature is anticipated to affect the isomer ratio. When the cyclization was carried out at higher temperature (r.t.; 25°C) and lower temperatures (Ϫ40°C, Ϫ20°C), the ratios decreased to 18 : 1, 53 : 1, and 59 : 1, respectively, ( Table 2 , entries 7,8,9). Thus, the optimal reaction temperature was concluded to be 0°C. Regarding the base, NMM was a slightly less effective base than triethylamine ( Table 2 , entry 10). Other tertiary amines, such as pyridine, diisopropylethylamine, N,N-dimethylaniline, and N,N-dimethylaminopyridine failed to produce smooth cyclization and generated by-products like N-ethoxycarbonylated 6a or its ethyl ester. These results confirmed that triethylamine was the most appropriate base. Thus, we succeeded in the establishment of a process for the stereoselective [5.7] -bicyclic ring closure of crystalline 6a using ethyl chloroformate and triethylamine in THF with ice-cooling.
Finally, the methyl ester of 7a obtained above was hydrolyzed with NaOH in H 2 O-EtOH solution at room temperature. The reaction reached completion in 3 h and the product 8a was extracted with AcOEt and crystallized from AcOBudiisopropyl ether to give crystalline 8a with a trace amount of 8b (methyl isomer) and 8c (thiazolidine ring isomer) and no trace of other isomers. The molecular orbital calculation done by MOPAC showed that 8a was the most thermodynamically stable compound among the possible isomers, explaining why retention of configuration took place during the hydrolysis. On the other hand, the thermodynamically less stable N-6 epimer of 7a was hydrolyzed with NaOH to give a mixture of the N-6 epimer of 8a and the isomerized compound 8a, which may proceed by a similar mechanism to that reported for the alkaline hydrolysis of acylamino-[5.5]-bicyclic thiazolidine lactam acid esters. 12) In summary, we have established a viable synthetic route to 8a from L-a -aminoadipic acid. This compound is a key intermediate for ER-40133, a promising antihypertension and cognitive heart failure medicine. This achievement depended on three main findings; 1) highly selective reduction with LiAlH(tert-BuO) 3 , 2) isolation of the linear key compound 6a, 3) stereoselective [5.7] -bicyclic ring cyclization. These findings will be useful not only to establish the large-scale synthesis process of our candidate compound, but also to expand and develop the peptide chemistry field.
Experimental
Melting points were determined on a Yamato MP21 melting points apparatus and are uncorrected. EI-MS and FAB-MS were taken with a JEOL JMS HX100. IR spectra were recorded on a Nicolet 205 FT-IR spectrometer. 1 H-NMR and 13 C-NMR spectra were measured on a Varian UNITY 400 or JEOL JNM-a600 using tetramethylsilane as an internal standard. Optical rotations were measured with JASCO DIP-1000 digital polarimeter.
Diphenylmethyl (2S,5R)-N-Benzyloxycarbonyl-5-methyl-6-oxopipecolic Acid (3a/3b) To a solution of 2 (100 g, 226 mmol) in THF-DMF (2 l/0.4 l) cooled in a dry ice MeOH bath was added dropwise 1 M LiHMDS THF solution (270 ml, 270 mmol) under reduced pressure over 20 min. After being stirred for 30 min, methyl iodide (28 ml, 450 mmol) was added dropwise over 30 min. The mixture was stirred for 3 h at the same temperature and a solution of acetic acid (30 ml) in toluene (0.5 l) was added. The cooling bath was removed and the flask was allowed to stand at room temperature. The mixture was diluted with toluene (1.5 l) and washed with water (2ϫ2 l), 10% NaHCO 3 solution (0.5 l), then 10% NaCl solution (1 l) and concentrated under reduced pressure to give a 4 : 1 crude mixture of 3a/3b as a yellow oil (100 g). This material was used for the next step without further purification.
Diphenylmethyl (2S,5R,6RS)-N-Benzyloxycarbonyl-6-hydroxy-5-methyl-2-pipecolic Acid (4a) 1 M LiAlH(tert-BuO) 3 THF solution (220 ml, 0.22 mol) was added dropwise to a solution of the crude 3a/3b (92 g, 0.2 mol) in AcOEt (920 ml) below 0°C and the solution was stirred for 2 h at the same temperature. Acetone (92 ml) was added and 20 min later, ice cooled 1 N HCl solution (920 ml) was added. The separated organic layer was washed with water (1 l), 5% aqueous NaHCO 3 solution (1.7 l), water (1 l), brine (1 l) and concentrated under reduced pressure to give a mixture of reduced com- pounds 4aϩ3b.
In a large-scale synthesis, this crude material was used for the next reaction without purification. For investigation of the reaction conditions, the crude was purified by silica gel column chromatography to give 4a as a 1 : 1 mixture (59% from 2). 1 40 (15H, m) .
HPLC conditions for 4a; column, ODS (YMC M-80) 4.6 mmϫ250 mmϩ 4.6 mmϫ150 mm; mobile phase, MeOH/H 2 O/AcONH 4 ϭ800/200/1; flow rate, 0.8 ml/min; detection; UV 220 nm; t R (4a)ϭ23, 27 min, t R (4b)ϭ39 min.
Methyl (2RS,4R)-2-[(1R,4S)-4-Diphenylmethoxycarbonyl-4-benzyloxycarbonylamino-1-methylbutyl]thiazolidine-4-carboxylate (5a)
The oily residue 4a including 3b obtained above was dissolved in a mixture of EtOH-MeOH (475 mlϩ25 ml), followed by addition of water (0.1 l), L-cysteine methyl ester hydrochloride (38.8 g, 0.22 mol), AcONa (18 g, 0.22 mol) and AcOH (13.2 ml, 0.22 mol). The mixture was stirred at room temperature for 18 h and washed with water (1 l), 0.25 N NaOH (1 l), water (0.5 l), 10% NaCl solution, then dried over MgSO 4 and concentrated under reduced pressure to give 5aϩ3b as a crude material (133 g). In a large-scale synthesis, this crude material was used directly for the next reaction. For spectral analysis, this crude was subjected to silica gel column chromatography to give a 1 : 1 mixture of the title compounds (50% from 2). IR (neat) 1520, 1720, 1760 cm HPLC conditions (5a); column, ODS (YMC, AM-312); mobile phase; 70%CH 3 CN, flow rate; 1.0 ml/min, detection; UV 254 nm, t R (5a)ϭ11, 12 min, t R (5b)ϭ10, 13 min.
Methyl (2RS,4R)-2-[(1R,4R)-4-Benzyloxycarbonylamino-4-carboxy-1-methylbutyl]thiazolidine-4-carboxylate (1 : 1 Mixture) (6a)
TFA (120 ml) was added dropwise to a solution of the oily product 5a (133 g, 0.22 mol) in anisole (130 ml) under ice-cooling and the reaction mixture was stirred for 1 h at room temperature. To the mixture were added 1.2 N HCl solution (1.32 l) and subsequently TBME (0.95 l) and n-hexane (0.5 l). The aqueous solution was separated and the organic layer was extracted with 1.2 N HCl solution (0.44 lϫ2). To the combined aqueous layer was added AcOEt (1.0 l), followed by adjustment of the pH to 3.7 with 5 M NaOH. The organic layer was separated and the aqueous layer was extracted with AcOEt (0.2 l). The combined organic layers were washed with 5% NaCl solution (0.5 l), then dried over MgSO 4 and concentrated under reduced pressure. To the residue was added AcOEt (40 ml). After the precipitate appeared, TBME (800 ml) was added and the mixture stirred overnight. The white solid was collected by filtration and washed with TBME (50 ml) to give 30 g of 6a as white crystals (32% 6 .55. HPLC conditions (6a); column; Chiralpak AD (Daicel 4.6 mmϫ250 mm), mobilephase; nhexane/iso-propanol/TFAϭ700/300/1, detection; UV 210, column temperature; 5°C; flow rate; 0.5 ml/min, t R (5a)ϭ24, 30 min, t R (6b)ϭ19, 28 min.
Improved Preparation Method for 6a TFA (30 ml) was added dropwise to a solution of the oily product 5aϩ3b (33.2 g, 0.055 mol) in anisole (30 ml) under ice-cooling and the reaction mixture was stirred for 1 h at room temperature. To the mixture were added 1.2 N HCl solution (330 ml) and subsequently TBME (240 ml) and n-hexane (120 ml). The aqueous solution was separated and the organic layer was extracted with 1.2 N HCl solution (100 mlϫ2). To the combined aqueous layer was added AcOiso-Bu (0.2 l), followed by adjustment of the pH to 3.7 with 5 N NaOH. The organic layer was separated and the aqueous layer was extracted with AcOiso-Bu (100 mlϫ2). The combined organic layers were diluted with heptane (660 ml) and stirred overnight. The white solid was collected by filtration and washed with heptane (50 ml) to give 6.5 g of 6a as white crystals (29%). The obtained material was identical with the sample prepared above by 1 H-NMR and HPLC analysis.
Methyl (3R,6S,9R,9aR)-6-Benzyloxycarbonylamino-9-methyl-5-oxooctahydroazepine[2,1-b]thiazole-3-carboxylate (7a) To a solution of 6a (30 g, 0.072 mol) in THF (300 ml) cooled in an ice bath was added dropwise triethylamine (8.5 g, 0.084 mol). The mixture was stirred and treated dropwise with a solution of ClCOOEt (8.34 g, 0.078 mol) in THF (73.2 ml) over 10 min, maintaining the temperature below 5°C. After being stirred for 5 h, 1 N HCl aqueous solution (92 ml) was added to terminate the reaction, followed by dilution with AcOEt (400 ml). The mixture was washed with water ( 1.1 l, 0.4 l) , aqueous 5% NaHCO 3 solution (0.4 l), brine (0.4 l) and concentrated under reduced pressure to give crude 7a as a colorless oil (27.7 g, 98%). The analytical sample of 7a was obtained by silica gel column chromatography (eluent; n-hexane : AcOEtϭ3 : 1 To a solution of 5a (67 g, 0.11 mol) in anisole (54 ml) was added TFA (92 ml) dropwise with ice-cooling and the reaction mixture stirred at room temperature for 3 h. AcOEt (0.5 l) was added to the solution, followed by NMM (124 ml, 1.4 mol) and EEDQ (59 g, 0.24 mol). After being stirred for 24 h, the whole was diluted with AcOEt (3 l) and washed with NaHCO 3 aqueous solution (2 l), water (3ϫ2 l), brine (1 l), then dried over MgSO 4 and concentrated under reduced pressure to give a 4 : 1 mixture of 7a/7c. The crude was subjected to silica gel column chromatography (n-hexane/AcOEtϭ2/1 to 1/1) to provide 26 g of 7a and 6.6 g of 7c as colorless oils.
Methyl (3R,6S,9R,9aS)-6-Benzyloxycarbonylamino-9-methyl-5-oxooctahydroazepine [ (3R,6S,9R,9aR)-6-Benzyloxycarbonylamino-9-methyl-oxooctahydroazepine[2,1-b]thiazole-3-carboxylic Acid (8a) To a solution of 7a (14.0 g, 36 mmol) in EtOH (84 ml) was added aqueous 1 N NaOH solution (84 ml, 216 mmol) dropwise at room temperature and the whole stirred for 2 h. The solution was added to a mixture of toluene and water (150 mlϩ150 ml) and the aqueous layer separated. The aqueous layer was acidified with aqueous 1 N HCl solution (90 ml) and extracted with AcOEt (2ϫ150 ml). The organic layer was separated, washed with water (3ϫ150 ml), brine (100 ml) then dried over MgSO 4 , and concentrated under reduced pressure to give a crude product. The residue was crystallized from a mixture of AcOBu (34 ml) and diisopropyl ether (100 ml) to give 8.8 g of 8a as white crystals (65% Diphenylmethyl (2S,5S,6RS)-N-Benzyloxycarbonyl-6-hydroxy-5-methyl-2-pipecolic Acid (4b) To a solution of 3b (3.9 g, 8.53 mmol) in THF (80 ml) cooled in a dry ice EtOH bath was added 1 M DIBAL-H THF solution (13.5 ml, 13.5 mmol) dropwise over 20 min. After being stirred for 1 h at the same temperature, acetone (40 ml) was added, followed by addition of AcOEt (200 ml) and 1 N HCl aqueous solution (200 ml). The organic solution was separated, washed with water (2ϫ100 ml), brine (100 ml) then dried over MgSO 4 and concentrated under reduced pressure to give a pale yellow oil. This oil was subjected to silica gel column chromatography (nhexane : AcOEtϭ4 : 1) to give 2.0 g of 4b as a colorless oil (51%). ture of 5b/5a) The crude mixture 4b obtained above was dissolved in a mixture of EtOH (120 ml), MeOH (1 ml) and water (6.65 ml). To the solution was added L-cysteine methyl ester (1.46 g, 8.53 mmol), AcONa (0.7 g, 8.53 mmol), and AcOH (0.48 ml, 8.53 mmol) at room temperature. After being stirred for 16 h, the whole was added to a mixture of AcOEt (500 ml) and NaHCO 3 aqueous solution (400 ml). The separated organic layer was washed with water (3ϫ300 ml), brine (200 ml), then dried over MgSO 4 and concentrated under reduced pressure to give a pale yellow oil. This oil was subjected to silica gel chromatography purification (n-hexane : AcOEtϭ4 : 1) to give 350 mg of crude 5b. The crude was purified by reversed phase column chromatography (YMC SH343, eluent; CH 3 CN : H 2 O : TFAϭ700 : 300 : 1) to provide ca. 5 : 1 mixture of 5b/5a as a pale yellow oil (360 mg, 10% from 4b). was added TFA (1 ml) dropwise with ice cooling. The mixture was stirred for 1 h and added to a mixture of aqueous 1.2 N HCl solution (5.5 ml), TBME (3 ml) and n-hexane (1.6 ml). The separated organic layer was washed with 1.2 N HCl solution (2ϫ2.5 ml) and the pH of the combined aqueous layers adjusted to 3.8 with aqueous NaHCO 3 solution and extracted with AcOEt (20 ml). The organic layer was separated, washed with water, brine, then dried over MgSO 4 and concentrated under reduced pressure to give 60 mg of a ca. 5 : 1 mixture of 6b/6a as a colorless oil (23%). 00 (5H, m), 2.84-3.35 (2H, m), 3.77 (3H, s), 3.98-4.05 (1H, m) 
